BST204 Protects Dexamethasone-Induced Myotube Atrophy through the Upregulation of Myotube Formation and Mitochondrial Function
Open Access
- 1 March 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (5), 2367
- https://doi.org/10.3390/ijerph18052367
Abstract
BST204 is a purified ginseng dry extract that has an inhibitory effect on lipopolysaccharide-induced inflammatory responses, but its effect on muscle atrophy is yet to be investigated. In this study, C2C12 myoblasts were induced to differentiate for three days followed by the treatment of dexamethasone (DEX), a corticosteroid drug, with vehicle or BST204 for one day and subjected to immunoblotting, immunocytochemistry, qRT-PCR and biochemical analysis for mitochondrial function. BST204 alleviates the myotube atrophic effect mediated by DEX via the activation of protein kinase B/mammalian target of rapamycin (Akt/mTOR) signaling. Through this pathway, BST204 suppresses the expression of muscle-specific E3 ubiquitin ligases contributing to the enhanced myotube formation and enlarged myotube diameter in DEX-treated myotubes. In addition, BST204 treatment significantly decreases the mitochondrial reactive oxygen species production in DEX-treated myotubes. Furthermore, BST204 improves mitochondrial function by upregulating the expression of peroxisome proliferator-activated receptor-γ coactivator-1α (PGC1α) in DEX-induced myotube atrophy. This study provides a mechanistic insight into the effect of BST204 on DEX-induced myotube atrophy, suggesting that BST204 has protective effects against the toxicity of a corticosteroid drug in muscle and promising potential as a nutraceutical remedy for the treatment of muscle weakness and atrophy.Keywords
This publication has 37 references indexed in Scilit:
- Implication of the Stereoisomers of Ginsenoside Derivatives in the Antiproliferative Effect of HSC-T6 CellsJournal of Agricultural and Food Chemistry, 2012
- Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle massJournal of Cachexia, Sarcopenia and Muscle, 2012
- Cdo Interacts with APPL1 and Activates AKT in Myoblast DifferentiationMolecular Biology of the Cell, 2010
- Mitochondrial fission and remodelling contributes to muscle atrophyThe EMBO Journal, 2010
- Cdo Binds Abl To Promote p38α/β Mitogen-Activated Protein Kinase Activity and Myogenic DifferentiationMolecular and Cellular Biology, 2009
- PGC-1 coactivators and skeletal muscle adaptations in health and diseaseCurrent Opinion in Genetics & Development, 2008
- Impaired Mitochondrial Substrate Oxidation in Muscle of Insulin-Resistant Offspring of Type 2 Diabetic PatientsDiabetes, 2007
- PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcriptionProceedings of the National Academy of Sciences of the United States of America, 2006
- Function and regulation of cullin–RING ubiquitin ligasesNature Reviews Molecular Cell Biology, 2005
- Activation of Akt2 Inhibits anoikis and apoptosis induced by myogenic differentiationCell Death & Differentiation, 2001